Browse the corpus

An aortopulmonary septal defect, also known as aortopulmonary window, is a rare congenital malformation involving a direct vascular connection between the ascending aorta and the main pulmonary artery, while the aortic and pulmonary valves remain anatomically distinct. The condition accounts for less than 0.6% of congenital heart defects and arises from incomplete embryologic septation of the truncus arteriosus. The defect permits a significant left-to-right shunt, leading to pulmonary overcirculation, volume overload, and early congestive heart failure. Associated cardiac anomalies, including an interrupted aortic arch or a ventricular septal defect, may be present. Infants typically present with tachypnea, poor feeding, failure to thrive, and a systolic murmur. Transthoracic echocardiography establishes the diagnosis and defines anatomic features. Initial management includes medical stabilization of heart failure, whereas definitive treatment requires early surgical repair to prevent pulmonary vascular disease. Progressive pulmonary hypertension and Eisenmenger physiology may develop without intervention. Prognosis is favorable with timely surgical correction. This activity for healthcare professionals is designed to enhance the learner's competence when evaluating and managing aortopulmonary septal defects. Participants deepen their understanding of the condition's etiology, risk factors, pathophysiology, clinical presentation, and evidence-based diagnostic and therapeutic recommendations, empowering them to collaborate with interprofessional teams caring for patients with this congenital cardiac condition. Objectives: Differentiate aortopulmonary septal defects from other congenital heart defects, such as truncus arteriosus and patent ductus arteriosus, based on clinical presentation and imaging findings. Implement best practices in managing aortopulmonary septal defects, encompassing echocardiographic evaluation, hemodynamic optimization, surgical correction, and follow-up surveillance. Apply evidence-based counseling strategies to educate families about clinical manifestations, treatment options, postoperative expectations, and lifelong follow-up for aortopulmonary septal defects.

Implement best practices in managing aortopulmonary septal defects, encompassing echocardiographic evaluation, hemodynamic optimization, surgical correction, and follow-up surveillance. Apply evidence-based counseling strategies to educate families about clinical manifestations, treatment options, postoperative expectations, and lifelong follow-up for aortopulmonary septal defects. Collaborate with cardiology, cardiac surgery, radiology, and nursing teams to develop individualized short- and long-term care plans for patients with aortopulmonary septal defects, improving overall health outcomes. Access free multiple choice questions on this topic.

An aortopulmonary septal defect, also known as an aortopulmonary window, is among the rarest congenital heart defects, accounting for 0.1% to 0.6% of all congenital heart diseases.[1][2] This anomaly may occur in isolation or in combination with other congenital heart lesions, including ventricular septal defects, interrupted aortic arch, tetralogy of Fallot, and, rarely, coronary artery anomalies.[3][4][5][6][7] By definition, an aortopulmonary window is a direct side-to-side connection between the ascending aorta and the main pulmonary artery, with the formation of a normal aortic valve and intact right ventricular outflow tract, distinguishing it from truncus arteriosus (see Video. Color Doppler Echocardiogram of Aortopulmonary Window).[8] Embryologically, an aortopulmonary window arises from incomplete septation of the conotruncal region, secondary to the failure of opposing conotruncal ridges to fuse.[9]

Aortopulmonary windows account for less than 0.6% of all congenital heart defects. Approximately 50% of cases are associated with additional congenital heart lesions, including other conotruncal defects (eg, tetralogy of Fallot, interrupted aortic arch, and D-transposition of the great arteries), coarctation of the aorta, ventricular septal defects, coronary artery anomalies, and tricuspid atresia.[10][11][12] Recent reports have identified anomalies involving the pulmonary arteries. Discontinuous pulmonary arteries may coexist with aortopulmonary windows.[13][14][15] Although these abnormal connections appear similar to other conotruncal malformations embryologically, the association with DiGeorge syndrome is unexpectedly low.[16] This finding suggests that aortopulmonary windows are not linked to abnormalities in cardiac neural crest development.[17]

An aortopulmonary window is a rare congenital heart defect, occurring in less than 0.6% of all congenital heart defects. Genetic associations include VACTERL syndrome (vertebral defects, anal atresia, cardiac defects, tracheoesophageal fistula, renal anomalies, limb abnormalities), Bohring-Opitz syndrome, and Goldenhar syndrome. No maternal exposures have been identified as causative factors.[18][19]

An aortopulmonary window arises during embryonic development from the incomplete septation of the common arterial trunk, creating an abnormal communication between the ascending aorta and the main pulmonary artery. The aortic and pulmonary semilunar valves form normally in an isolated aortopulmonary window.[20] The defect is located between the semilunar valves and the branch pulmonary arteries. Several anatomic classifications exist, with the most commonly used system dividing the defect into 3 types—type 1 (proximal defect), type 2 (distal defect), and type 3 (total defect with complete absence of the aortopulmonary septum).[21][22] Type 1 is the most common form of aortopulmonary window. The size of the connection is variable but typically large, unrestrictive, and hemodynamically significant. The aortopulmonary window is small and pressure-restrictive in less than 10% of cases.[23]

Diagnosis of an isolated aortopulmonary window is possible in utero using fetal echocardiography.[24] The more typical presentation occurs in the neonatal period or early infancy.[25][26][27] Clinical manifestations result from pulmonary overcirculation as pulmonary vascular resistance (PVR) decreases over the first weeks of life. This hemodynamic change produces a large left-to-right shunt. Common symptoms include diaphoresis, particularly with feeding; tachypnea; tachycardia; poor weight gain; and exacerbation of respiratory symptoms during viral infections. Physical examination often reveals a hyperdynamic precordium and a mitral valve rumble. Peripheral pulses are frequently bounding due to decreased systemic diastolic blood pressure secondary to aortic flow reversal in diastole. A continuous murmur is uncommon because the aortopulmonary connection is typically large, preventing the development of a significant pressure gradient. An aortopulmonary window can be associated with other types of congenital heart defects, and the coexisting defect can modify the clinical presentation. A pulmonary ejection murmur and a pulmonary valve click may be observed when combined with tetralogy of Fallot. Neonates can present with cardiogenic shock as the ductus arteriosus constricts when the aortopulmonary window occurs with an interrupted aortic arch or severe coarctation of the aorta.[28] Less frequently, the aortopulmonary window can be restrictive and produce milder symptoms of pulmonary overcirculation. In these cases, a continuous heart murmur may be present. Rarely, diagnosis of an aortopulmonary window is delayed until later childhood or adulthood. Late presentation can include features of Eisenmenger syndrome, such as cyanosis and clubbing.[29][30][31] Detailed hemodynamic evaluation remains essential in late presenters, as some patients may remain candidates for repair if PVR is acceptable, or an appropriate response is observed during vasodilator testing.[32][33]

Diagnosis of an aortopulmonary window is established by echocardiography after suspicion of a large left-to-right shunt. The connection is usually nonrestrictive, and color Doppler echocardiography typically does not detect a high-velocity jet. High clinical suspicion warrants evaluation with two-dimensional imaging, which is generally sufficient to assess aortopulmonary window communication (see Video. Subcostal Echocardiogram of Aortopulmonary Window). If echocardiographic imaging is inadequate, computed tomography can delineate the aortopulmonary window (see Image. Three-Dimensional Computed Tomography Reconstruction of Aortopulmonary Window). Computed tomography angiography also detects coronary anomalies that may not be well visualized on echocardiography, reducing the risk of intraoperative complications if overlooked during preoperative assessment. Echocardiography further identifies associated lesions, including tetralogy of Fallot, atrial septal defects, ventricular septal defects, coarctation of the aorta, and interrupted aortic arch. Cardiac catheterization typically contributes little to diagnosis in infants. In late presentations, particularly in patients with cyanosis, catheterization is used to evaluate PVR in patients with Eisenmenger physiology. Pulmonary reactivity testing during catheterization determines the feasibility of surgical repair.[34] Chest radiography typically demonstrates cardiomegaly and increased pulmonary vascular markings. Electrocardiography shows tachycardia and increased right- and left-sided voltages.

Surgical intervention is recommended at the time of diagnosis because little physiological adaptation occurs, and the risk of developing irreversible pulmonary hypertension increases over time. The aortopulmonary window remains nonrestrictive and does not become hemodynamically less significant with age. Surgical repair involves separating the great arteries with suture division or patch closure of the aorta and the main pulmonary artery. Outcomes are generally favorable when repair is performed early in infancy, with low surgical mortality.[35][36] Concomitant cardiac defects should be corrected or palliated during the same operation. Smaller aortopulmonary windows may be closed primarily using double ligation or suture closure, with low surgical mortality.[37][38] The presence of associated congenital heart disease increases surgical complexity and may worsen outcomes. Catheter-based closure of aortopulmonary windows using double-disk devices, including atrial septal defect and patent ductus arteriosus (PDA) devices, has been reported in case studies for defects that are typically restrictive, permitting closure later in childhood.[39][40][41] Postoperative stenosis of the aorta or pulmonary arteries, including the main pulmonary and branch pulmonary arteries, may occur. Hemodynamically significant stenosis may be treated with subsequent cardiac catheterization using balloon angioplasty or stent implantation. Transcatheter aortic interventions may be required for residual arch obstruction in patients undergoing interrupted aortic arch repair.[42] Medical management before surgery may involve anticongestive medications such as diuretics (eg, furosemide and chlorothiazide). Digoxin can provide temporary symptomatic improvement but does not significantly alter disease progression. Afterload reduction with angiotensin-converting enzyme inhibitors may be considered. Medical therapy requires caution due to potential abnormal renal perfusion.

Truncus arteriosus is the lesion most frequently mistaken for an aortopulmonary window, but it has a single truncal valve rather than 2 separate semilunar valves. Early pathophysiology of truncus arteriosus resembles that of an aortopulmonary window. Large PDA devices produce comparable hemodynamics. A window-type PDA connects the proximal descending aorta to the left pulmonary artery near the bifurcation. In contrast, an aortopulmonary window connects the ascending aorta to the main pulmonary artery. Large ventricular septal defects produce similar physiological effects but can be readily distinguished from an aortopulmonary window based on anatomical location and valve morphology.

The prognosis for an isolated aortopulmonary window is favorable when early surgical closure is performed, and the development of pulmonary vascular disease is prevented. Late diagnosis can result in pulmonary hypertension and Eisenmenger syndrome, which carry a poor prognosis. The presence of an aortopulmonary window associated with other congenital heart lesions increases surgical complexity and may adversely affect outcomes.

Complications of a missed diagnosis include the development of Eisenmenger syndrome.[43] Surgical repair may be associated with residual defects, including branch pulmonary artery stenosis and residual aortopulmonary window, which may require future intervention.[44] Recurrent laryngeal nerve injury should be considered in cases of postoperative hoarseness or choking during feeding.[45]

Diagnosis of an aortopulmonary window is typically established by echocardiography. High clinical suspicion of a large left-to-right shunt and bounding pulses should prompt targeted echocardiographic evaluation. Late repair of an aortopulmonary window carries a risk of persistent pulmonary hypertension, and preoperative cardiac catheterization is recommended before delayed repair. A low threshold for postoperative catheterization is advised to assess PVR. Early surgical repair of an aortopulmonary window generally yields an excellent long-term prognosis.

An aortopulmonary window is a rare congenital anomaly featuring a direct communication between the ascending aorta and the main pulmonary artery, usually with normally formed semilunar valves. Significant shunting leads to pulmonary overcirculation, left-sided volume overload, and, if untreated, progressive pulmonary hypertension or Eisenmenger physiology. Neonates may present with tachypnea, diaphoresis, poor weight gain, or heart failure, while late presentations include cyanosis and pulmonary vascular disease. Diagnosis relies on echocardiography, with computed tomography or catheterization used for anatomical clarification or hemodynamic assessment. Early surgical repair is the definitive treatment to prevent irreversible pulmonary complications. Optimal outcomes require an interprofessional team including pediatric cardiologists, cardiac surgeons, pediatric anesthesiologists, pediatric cardiac intensivists, and pediatric radiologists. Cardiac and critical care nurses provide postoperative monitoring, pharmacists manage medications, and specialty care nurses coordinate care and educate families. Lifelong cardiology follow-up is recommended to identify late complications, thereby enhancing patient safety, supporting recovery, and improving long-term outcomes.